Device Week, 19 February 2021 – A Mix Of Insulin Pump; Liquid Biopsy; Transcatheter Device News
Citeline Podcasts - A podcast by Citeline
Categories:
In this week’s podcast, Medtech Insight's managing editor Marion Webb discusses Guardant Health’s launch of a new liquid biopsy test to detect early-stage colorectal cancer. Deputy editor Reed Miller discusses Canadian-based Neovasc’s recent funding and what it could mean for its Reducer transcatheter technology. UK-based reporter Barnaby Pickering gives an overview of the fast-growing insulin pump market. Listen to the podcast via the player below: Guardant Health Launches Liquid Biopsy Test For Detecting Colorectal Cancer Recurrence Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021 Neovasc Maintains Investor Confidence Despite FDA Struggles; Sells $72M In Stock For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode:
